Exhaled nitric oxide in patients with sleep apnea

Sleep

Volumn 22, Issue 2, 1999, Pages 231-235

  Agustí, Alvar G N ^a   Barbé, Ferrán ^a   Togores, Bernat ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Apnea; Cardiovascular diseases; OSAS; Sleep apnea syndrome

Indexed keywords

NITRIC OXIDE;

ARTERIAL OXYGEN SATURATION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXHALATION; FORCED EXPIRATORY FLOW; HUMAN; HYPERTENSION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SLEEP APNEA SYNDROME; VITAL CAPACITY;

ADULT; ANALYSIS OF VARIANCE; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; RESPIRATION; SEVERITY OF ILLNESS INDEX; SLEEP APNEA SYNDROMES;

EID: 0033559481     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Guilleminault C, Robinson A. Sleep-disordered breathing and hypertension. Past lessons, future directions. Sleep 1997;20:806-811.
2. Strandling J, R.J.O. Davies RJO. Sleep apnea and hypertension-What a Mess! Sleep 1997;20:789
3. Young T, Peppard P, Palta M, Hla KM, L. Finn, Morgan B, Skatrud J. Population-based study of sleep-disordered breathings as a risk factor for hypertension. Arch Intern Med 1997;157:1746-1752.
4. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea:Facts and theory. Am J Med 1995;98:118-128.
5. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988;94:1200-1204.
6. Moncada S, Higgs A. The L-Arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
7. Loscalzo J. Nitric oxide and vascular disease. N Engl J Med 1995;333:251-253.
8. Barnes PJ, Kharitonov SA. Exhaled nitric oxide:a new lung function test. Thorax 1996;81:233-237.
9. Kharitonov SA, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements:recommendations. EurRespirJ 1997;10:1683-1693.
10. Schilling J, Holzer P, Guggenbach M, Gyurech D, Marathia K, Geroulanos S. Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. EurRespirJ 1994;7:467-471.
11. Kharitonov SA, Cailes JB, Black CM, Du B, Barnes PJ. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997;52:1051-1055.
12. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorhism of the endothelial nitric oxide synthase gene. Nature Med 1996;2:41-45.
13. Kharitonov SA, Robbins RA, Yates D, Keatings V, Barnes PJ. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995;152:609-612.
14. Persson MG, Zetterstróm O, Agrenius V, Ihre E, Gustafsson LE. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994;343:146-147.
15. Barbé F, Pericás J, Muñoz A, Findley LJ, Antó JM, Agusti AGN. Automobile accidents in patients with sleep apnea syndrome: a combined epidemiological and mechanistic study. Am J Respir Crit Care Med 1998;158:18-22
16. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-135.
17. American Thoracic Society Official Statement. 1995. Standardization of Spirometry. Am J Respir Crit Care Med 1994;152:1107-1136.
18. Roca J, Sanchis J, Agustí-Vidal A, Segarra D, Navajas D, Rodriguez-Roisín R, Casan P, Sans S. Spirometric reference values for a mediterranean population. Bull Eur Physiopathol Respir 1986;22:217-224.
19. Agustí AGN, Villaverde JM, Togores B. Exhaled nitric oxide is increased but not modulated during exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1999 (submitted)
20. Olopade ChO, Christon JA, Zakkar M, Hua C-W, Swedler WI, Schell PA, Rubinstein I. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 1997;111:500-504.
21. Barnes PJ, Kharitonov SA, Yates DH. Exhaled nitric oxide and airway inflammation in asthma. Q J Med 1996;89:871-872.
22. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, P. Howarth P, Redington A, Bousquet J, Godard P, Holgate S, Polak JM. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-1513.
23. Douglas NJ, Luke M, Mathur R. Is the sleep apnoea/hypopnoea syndrome inherited? Thorax 1993;48:719-721.
24. Mathur R, Douglas NJ. Family studies in patients with the sleep apnea-hypopnea syndrome. Ann Intern Med 1995; 122:174-178.
25. Iacoviello L, Di Castelnuovo A, De Knjff P, D'Orazio A, Amore C, Arboretti R, Kluft C, Donati MB. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998;338:79-85.
26. Lindpaintner K, Pfeffer MA, Kreutz R, Stamper MJ, Grodstein F, LaMotte F, Buring J, Hennekens ChH. A prospective evualuation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
27. Cambien F. The angiotensin-converting enzyme (ACE) genetic polymorphism:its relationship with plasma ACE level and myocardial infarction. Clin Genet 1994;46:94-101.
28. Tiret L, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-913.
29. Behn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parenteral history of myocardial infarction. Clin Genet 1993;44:298-301.
30. Morise T, Takeuchi Y, Takeda R. Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet. 1993;343:125
31. Tiret L, Poirier O, L. Lecerf J-P, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993;341:991-992.
32. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983;24:1070-1076.
33. Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arterioscler Thromb 1986;6:505-510.
34. Rengstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992;39:1183-1186.
35. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol:modifications of low density lipoprotein that increase its atherogenecity. N Engl J Med 1989;320:915-924.